Isometric Holdings Inc., parent company to Isometric Micro Molding Inc. and Isometric Tool & Design Inc., has been acquired by its leadership team, Donna Bibber and Wayne Shakal, effective September 20, 2021. Isometric Micro Molding is an ISO 13485 certified micro molding contract manufacturer for medical, implantable, and pharma market segments such as intraocular, cardiovascular, neuromodulation, orthopedic, blood glucose monitoring, and various other drug delivery platforms. The company also offers ultra-precision tooling, micro automated assembly, micro 3D printing, and CT scanning.
“This is an exciting new chapter for Isometric’s history. We have embraced and adapted to change for 31 years, but one thing will surely remain the same and that is our strong core values and processes that have shaped Isometric into a trusted partner,” said former VP of Business Development and now CEO Donna Bibber in a news release.
Added Former VP of Operations and now President Wayne Shakal: “This is the progressive realization of a life-long goal that was made possible when Donna and I partnered with Mike Hudalla, the prior owner, many years ago. We are excited to continue to serve all of our wonderful customers and will do so with a shared passion to exceed their expectations.”
Throughout its history, Isometric Micro Molding has followed a philosophy called “Process of Discovery,” with three main initiatives:
1. Discover Innovative Ideas by thinking beyond the norm with fresh, novel approaches that work.
2. Integrate Statistical Processes to guarantee robust processes using automated solutions.
3. Eliminate Customer Concern by anticipating potential problems before they occur.
“As partners in precision with our medical and drug delivery OEM customers over the last several years, we are experiencing unprecedented growth and prosperity. This growth has fueled the need an additional 6k sq ft of cleanroom manufacturing and support space scheduled to be completed in March 2022,” said Bibber.